Print Page     Close Window     

SEC Filings

424B3
BIOTIME INC filed this Form 424B3 on 02/04/2019
Entire Document
 

 

 

ASTERIAS BIOTHERAPEUTICS, INC.

CONDENSED STATEMENTS OF COMPREHENSIVE LOSS

(IN THOUSANDS)

(UNAUDITED)

 

  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2018   2017   2018   2017 
NET LOSS  $(4,454)  $(6,809)  $(13,748)  $(21,824)
Other comprehensive loss:                    
Unrealized loss on marketable equity securities, net of taxes       (764)       (2,892)
Realized gain on marketable equity securities, net of taxes       118        118 
Total other comprehensive loss       (646)       (2,774)
COMPREHENSIVE LOSS  $(4,454)  $(7,455)  $(13,748)  $(24,598)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 F-34 

© Copyright BioTime, Inc.